Literature DB >> 35419128

Primary Sjögren's Syndrome Presenting as Recurrent Ischemic Strokes.

Praveen Kesav1, Syed Irteza Hussain1, Preeti Devnani1, Rajaie Namas2, Khalid Al-Sharif1, Moncy Thomas1, Basel Altrabulsi3, Seby John1.   

Abstract

Primary Sjogren's Syndrome (PSS) is an autoimmune exocrinopathy, with protean manifestations affecting multiple organ systems. Neurological manifestations are documented in about 20% of PSS cohorts in literature, with peripheral manifestations being commoner. Central nervous system manifestations of PSS (CNS-SS) encompass ischemic strokes, demyelinating lesions, aseptic meningitis, encephalitis, cerebellar ataxia, cognitive impairment and movement disorders. Ischemic stroke as presenting manifestation of PSS is extremely rare. We hereby describe a 50-year-old male, who presented for evaluation of 2 episodes of discrete focal neurological deficits over a duration of 6 weeks, with neuro-imaging findings revealing evidence of acute-subacute bihemispheric infarcts. Further evaluation revealed evidence of strongly positive anti phospholipid antibodies (aPL), indirect immunofluorescence antinuclear antibody (IIF-ANA), anti Sjögren's syndrome-A (SS-A/Ro) and anti-Ribonuclear protein (RNP) antibodies, with histopathological evidence of periductal and periacinar lymphocytic infiltration as well as acinar atrophy and interstitial fibrosis of minor salivary glands on lip biopsy, consistent with a diagnosis of Sjögren's syndrome, constituting a diagnosis of Antiphospholipid syndrome (APS) associated with PSS.
© The Author(s) 2021.

Entities:  

Keywords:  anti phospholipid antibody syndrome; primary Sjogren’s syndrome; recurrent strokes

Year:  2021        PMID: 35419128      PMCID: PMC8995579          DOI: 10.1177/19418744211048593

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  10 in total

1.  Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients.

Authors:  A L Fauchais; M Lambert; D Launay; U Michon-Pasturel; V Queyrel; N Nguyen; M Hebbar; E Hachulla; B Devulder; P Y Hatron
Journal:  Lupus       Date:  2004       Impact factor: 2.911

Review 2.  The overlap of Sjögren's syndrome with other systemic autoimmune diseases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Semin Arthritis Rheum       Date:  2006-09-22       Impact factor: 5.532

3.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

Review 4.  Primary Sjögren's Syndrome.

Authors:  Xavier Mariette; Lindsey A Criswell
Journal:  N Engl J Med       Date:  2018-03-08       Impact factor: 91.245

5.  Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome.

Authors:  Sandra Gofinet Pasoto; Henrique Pires Chakkour; Renato Romera Natalino; Vilma S T Viana; Cleonice Bueno; Alessandro Cavalcanti Lianza; José Lázaro de Andrade; Mauricio Levy Neto; Ricardo Fuller; Eloisa Bonfa
Journal:  Clin Rheumatol       Date:  2012-06-13       Impact factor: 2.980

6.  Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.

Authors:  Manuel Ramos-Casals; Norma Nardi; Pilar Brito-Zerón; Sira Aguiló; Victor Gil; German Delgado; Albert Bové; Josep Font
Journal:  Semin Arthritis Rheum       Date:  2006-04       Impact factor: 5.532

7.  Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates.

Authors:  E L Alexander; M R Ranzenbach; A J Kumar; W E Kozachuk; A E Rosenbaum; N Patronas; J B Harley; M Reichlin
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

8.  Sjögren's syndrome presenting as ischemic stroke.

Authors:  M Bragoni; V Di Piero; R Priori; G Valesini; G L Lenzi
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

Review 9.  Neurologic Manifestations of Primary Sjögren Syndrome.

Authors:  Mary Margaretten
Journal:  Rheum Dis Clin North Am       Date:  2017-08-23       Impact factor: 2.670

10.  ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?

Authors:  J Payet; R Belkhir; J E Gottenberg; E Bergé; F Desmoulins; O Meyer; X Mariette; R Seror
Journal:  RMD Open       Date:  2015-04-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.